Patient characteristics
. | cGVHD . | No cGVHD . | P . |
|---|---|---|---|
| Number | 30 | 27 | NA |
| Median age, y | 44 | 36 | .22 |
| Sex | .43 | ||
| Male | 17 | 12 | |
| Female | 13 | 15 | |
| Diagnosis | NA | ||
| Chronic myeloid leukemia | 11 | 5 | |
| Acute lymphoblastic leukemia | 3 | 1 | |
| Acute myeloid leukemia | 8 | 7 | |
| Myelodysplastic syndrome | 7 | 5 | |
| Multiple myeloma | 1 | 0 | |
| Non-Hodgkin lymphoma | 0 | 5 | |
| Hodgkin lymphoma | 0 | 3 | |
| Aplastic anemia | 0 | 1 | |
| Conditioning regimen | .09 | ||
| Myeloablative | 29 | 22 | |
| Nonmyeloablative | 1 | 5 | |
| Stem cell source | <.001 | ||
| Bone marrow | 26 | 10 | |
| Peripheral blood | 4 | 17 | |
| Donor | .06 | ||
| Related | 13 | 19 | |
| Unrelated | 17 | 8 | |
| HLA | .09 | ||
| Matched | 25 | 25 | |
| Mismatched | 5 | 2 | |
| Sex match, patient/donor | NA | ||
| M/M | 7 | 6 | |
| M/F | 10 | 6 | |
| F/M | 4 | 4 | |
| F/F | 9 | 11 | |
| Acute GVHD grade II to IV | .01 | ||
| No | 14 | 22 | |
| Yes | 16 | 5 | |
| Median time after transplantation | |||
| (range), mo | 24 (7-124) | 19 (5-127) | .08 |
| Immunosuppressive drugs | 29 | 12 | <.001 |
| cGVHD grade | NA | ||
| Mild | 23 | NA | |
| Moderate | 6 | NA | |
| Severe | 1 | NA |
. | cGVHD . | No cGVHD . | P . |
|---|---|---|---|
| Number | 30 | 27 | NA |
| Median age, y | 44 | 36 | .22 |
| Sex | .43 | ||
| Male | 17 | 12 | |
| Female | 13 | 15 | |
| Diagnosis | NA | ||
| Chronic myeloid leukemia | 11 | 5 | |
| Acute lymphoblastic leukemia | 3 | 1 | |
| Acute myeloid leukemia | 8 | 7 | |
| Myelodysplastic syndrome | 7 | 5 | |
| Multiple myeloma | 1 | 0 | |
| Non-Hodgkin lymphoma | 0 | 5 | |
| Hodgkin lymphoma | 0 | 3 | |
| Aplastic anemia | 0 | 1 | |
| Conditioning regimen | .09 | ||
| Myeloablative | 29 | 22 | |
| Nonmyeloablative | 1 | 5 | |
| Stem cell source | <.001 | ||
| Bone marrow | 26 | 10 | |
| Peripheral blood | 4 | 17 | |
| Donor | .06 | ||
| Related | 13 | 19 | |
| Unrelated | 17 | 8 | |
| HLA | .09 | ||
| Matched | 25 | 25 | |
| Mismatched | 5 | 2 | |
| Sex match, patient/donor | NA | ||
| M/M | 7 | 6 | |
| M/F | 10 | 6 | |
| F/M | 4 | 4 | |
| F/F | 9 | 11 | |
| Acute GVHD grade II to IV | .01 | ||
| No | 14 | 22 | |
| Yes | 16 | 5 | |
| Median time after transplantation | |||
| (range), mo | 24 (7-124) | 19 (5-127) | .08 |
| Immunosuppressive drugs | 29 | 12 | <.001 |
| cGVHD grade | NA | ||
| Mild | 23 | NA | |
| Moderate | 6 | NA | |
| Severe | 1 | NA |
NA indicates not applicable.